PUBLISHER: The Business Research Company | PRODUCT CODE: 1760570
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760570
An insulin infusion pump is a small, wearable device designed for the continuous delivery of insulin to individuals with diabetes, helping maintain optimal blood glucose levels. It administers insulin through a catheter placed under the skin, offering more precise and flexible management compared to multiple daily injections.
The main types of insulin infusion pumps include continuous subcutaneous insulin infusion (CSII) pumps, insulin delivery pens, and wearable insulin pumps. Continuous Subcutaneous Insulin Infusion (CSII) pumps are medical devices that deliver a steady, continuous dose of rapid-acting insulin via a small catheter placed under the skin. Technologies involved in these pumps include remote monitoring systems, closed-loop systems, and smart insulin pumps. These devices are used in various settings such as hospitals, home care environments, and diabetes clinics.
The insulin infusion pumps market research report is one of a series of new reports from The Business Research Company that provides insulin infusion pumps market statistics, including the insulin infusion pumps industry's global market size, regional shares, competitors with the insulin infusion pumps market share, detailed insulin infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the insulin infusion pumps market. This insulin infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The insulin infusion pump market size has grown rapidly in recent years. It will grow from $6.33 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historical period can be attributed to factors such as the rising incidence and prevalence of diabetes, the increasing rate of obesity, the growing demand for integrated systems, heightened awareness and education, and improved reimbursement policies.
The insulin infusion pump market size is expected to rapid growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to factors such as expanding access to telehealth services, a rise in chronic disease cases, increasing demand for personalized medicine, higher healthcare expenditure, and growing awareness among both physicians and patients. Key trends in the forecast period include advancements in closed-loop systems, the integration of artificial intelligence (AI) and machine learning, technological progress in wireless connectivity, advancements in pump miniaturization, and the integration of wearable devices.
The insulin infusion pump market is projected to grow as the prevalence of diabetes continues to rise. Diabetes is a chronic condition in which the body struggles to regulate blood sugar or glucose levels. The increasing rates of diabetes are primarily attributed to sedentary lifestyles and poor dietary choices, which lead to obesity, insulin resistance, and higher incidences of type 2 diabetes. Insulin infusion pumps help manage diabetes by delivering continuous, precise doses of insulin, ensuring stable blood glucose levels. They reduce the need for frequent injections, offering convenience and better control over blood sugar, ultimately improving diabetes care. For example, in June 2024, the National Health Service (NHS) reported that in 2023, 3,615,330 individuals in the UK were diagnosed with non-diabetic hyperglycemia or pre-diabetes, marking an 18% increase from 3,065,825 cases in 2022. This growing prevalence of lifestyle-related diseases is expected to drive the expansion of the medical device safety testing market.
Leading companies in the insulin infusion pump market are focusing on developing innovative products, such as insulin patch pump systems, to improve convenience, portability, and offer more discreet and comfortable insulin delivery options for patients. Insulin patch pumps are small, wearable devices that administer insulin through the skin, eliminating the need for traditional tubing. In November 2023, ViCentra BV, a Netherlands-based medical device company, launched a hybrid closed-loop system that combines its Kaleido insulin patch pump with the Diabeloop DBLG1 algorithm and Dexcom G6 continuous glucose monitoring. This integrated artificial pancreas automatically adjusts insulin dosing in real-time, significantly reducing hypoglycemia and improving glucose control and time in range for individuals with type 1 diabetes. The system is user-friendly, requires minimal setup without fingerstick tests, and uploads data to a cloud platform for easy monitoring by both users and healthcare providers.
In May 2023, Medtronic plc, an Ireland-based medical technology company, acquired EOFlow for $738 million. The acquisition is part of Medtronic's strategy to enhance its diabetes management portfolio by integrating EOFlow's cutting-edge wearable insulin delivery technology. EOFlow Co. Ltd., based in South Korea, is a medical technology company focused on developing wearable and disposable insulin patch pumps to improve diabetes management.
Major players in the insulin infusion pump market are Pfizer Inc., Roche Holding AG, Sanofi S.A., Medtronic plc, Eli Lilly and Company, Becton, Dickinson and Company, Baxter International Inc., Terumo Corporation, Smiths Group plc, Moog Inc., ICU Medical Inc., Insulet Corporation, MicroPort Scientific Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, B. Braun Melsungen AG, Beta Bionics Inc., SOOIL Development Co. Ltd., Fresenius SE & Co. KGaA, Shinmyung Mediyes Co. Ltd.
North America was the largest region in the insulin infusion pump market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in insulin infusion pump report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the insulin infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The insulin infusion pump market consists of revenues earned by entities providing services such as bolus insulin delivery, customizable dosing schedules, and blood glucose monitoring integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The insulin infusion pump market also includes sales of tubed insulin pumps, rechargeable and disposable pump units, smart pump controllers, and integrated CGM-compatible devices designed to improve glycemic control in diabetes patients. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Insulin Infusion Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on insulin infusion pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for insulin infusion pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insulin infusion pump market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.